Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep;81(3):452-482.
doi: 10.1016/j.jinf.2020.05.069. Epub 2020 Jun 11.

Tumor biomarkers predict clinical outcome of COVID-19 patients

Bangshun He  1 , Aifang Zhong  2 , Qiuyue Wu  3 , Xiong Liu  4 , Jie Lin  5 , Chao Chen  6 , Yiming He  6 , Yanju Guo  3 , Man Zhang  3 , Peiran Zhu  3 , Jian Wu  3 , Changjun Wang  7 , Shukui Wang  8 , Xinyi Xia  9
Affiliations
Comment

Tumor biomarkers predict clinical outcome of COVID-19 patients

Bangshun He et al. J Infect. 2020 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare no competing interests

Comment on

References

    1. Fu L., Wang B., Yuan T., Chen X., Ao Y., Fitzpatrick T. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020;80(6):656–665. - PMC - PubMed
    1. Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. Jama. 2020 - PubMed
    1. Verity R., Okell L.C., Dorigatti I., Winskill P., Whittaker C., Imai N. Estimates of the severity of coronavirus disease 2019: a model-based analysis. The Lancet Infectious diseases. 2020 - PMC - PubMed
    1. Bombardieri E., Seregni E., Bogni A., Ardit S., Belloli S., Busetto A. Evaluation of cytokeratin 19 serum fragments (CYFRA 21-1) in patients with lung cancer: results of a multicenter trial. The International journal of biological markers. 1994;9(2):89–95. - PubMed
    1. Yang Q., Zhang P., Wu R., Lu K., Zhou H. Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible? Disease markers. 2018;2018 - PMC - PubMed

Substances